Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention. Charles Roberts, Gabriel Otte, Riley Ennis, and Michael Otte launched the company in 2014 in South San Francisco, California.

Administration

Accounting & Finance

Software Engineering

Other Engineering

People & HR

Product

Legal

Sales & Business Development

Operations

Data Science

Quality Assurance

South San Francisco, CA, USA

United States

North America

Freenome

Innovation Endeavors invests in visionary founders, transformational technology and emergent ecosystems for a new world.

Innovation Endeavors

Investing in visionary founders, transformational technology and emergent ecosystems for a new world.